Jari Yli-Kauhaluoma

Jari Yli-Kauhaluoma

Drug Research Program, University of Helsinki

Affiliated withUniversity of Helsinki

Research Area

Biography

Jari Yli-Kauhaluoma has not added Biography.
If you are Jari Yli-Kauhaluoma and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
Screening for <em>Thermotoga maritima</em> Membrane-Bound Pyrophosphatase Inhibitors
Publication title

Cited by 6

2019

Other Publications

Article
Year
On the hydrolytic behavior of tinidazole, metronidazole, and ornidazole.

Journal of pharmaceutical sciences| PubMed ID: 12661060

2003
2005
2005
A modification of the Hammett equation for predicting ionisation constants of p-vinyl phenols.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences| PubMed ID: 15979536

2005
2005
2005
2006
2006
Pharmacological properties of the ubiquitous natural product betulin.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences| PubMed ID: 16716572

2006
2006
Microplate screening assay for binding of ligands to bovine or reindeer beta-lactoglobulins.

Journal of biochemical and biophysical methods| PubMed ID: 16766039

2006
2007
2007
2007
2007
2007
2007
A new insight into solid-state conformation of macrolide antibiotics.

Bioorganic & medicinal chemistry| PubMed ID: 17936632

2008
2007
Acetylcholinesterase inhibitory guided fractionation of Melissa officinalis L.

Bioorganic & medicinal chemistry| PubMed ID: 19070498

2009
2009
2009
Synthesis, structure characterization, and enzyme screening of clenbuterol glucuronides.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences| PubMed ID: 19447177

2009
2009
The binding of synthetic retinoids to lipocalin beta-lactoglobulins.

Journal of medicinal chemistry| PubMed ID: 19938842

2010
Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases.

Drug metabolism and disposition: the biological fate of chemicals| PubMed ID: 20007669

2010
Synthesis and anti-leishmanial activity of heterocyclic betulin derivatives.

Bioorganic & medicinal chemistry| PubMed ID: 20116263

2010
Anti-leishmanial activity of betulin derivatives.

The Journal of antibiotics| PubMed ID: 20139867

2010
HIV-1 Tat-peptide inhibits protein kinase C and protein kinase A through substrate competition.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences| PubMed ID: 20433920

2010
2011
2010
2011
2011
Current status and future prospects of C1 domain ligands as drug candidates.

Current topics in medicinal chemistry| PubMed ID: 21513495

2011
2011
2011
2012
2013
2013
2013
2013
2013
2014
2014
Exploring marine resources for bioactive compounds.

Planta medica| PubMed ID: 25203732

2014
2014
2014
Synthesis and biological evaluation of 2-arylbenzimidazoles targeting Leishmania donovani.

Bioorganic & medicinal chemistry letters| PubMed ID: 25827525

2015
2015
2015
2015
2015
2015
Synthesis of 1,3,6-Trisubstituted Azulenes.

The Journal of organic chemistry| PubMed ID: 26528547

2015
2016
2016
2016
2016
2017
2017
2017
2017
2017
2018
2018
2018
2018
2018
2018
2018
Azulene-based compounds for targeting orexin receptors.

European journal of medicinal chemistry| PubMed ID: 30077889

2018
2018
2018
2018
2019
2019
2019
2019
2019
2019
2019
2018